Menu
Demo
Demo

News and Insights

Explore our resources

Use the content type and topic filters to narrow down results

Content Type
  1. All
  2. Company Overview/Updates
  3. Events
  4. Industry Insights
  5. Press Releases
  6. Resources
  7. Solutions Overview/Updates
Content Topic
  1. All
  2. Advanced Access Anywhere
  3. Advanced Benefit Verification
  4. Advanced Gateway
  5. Advanced Prior Authorization
  6. Analytics & Reporting
  7. Annual Reverification
  8. ARx Patient Solutions Pharmacy
  9. AssistRx Patient Solutions
  10. CoAssist
  11. e-Consent
  12. e-Coverage
  13. e-Prescribing
  14. e-Prior Authorization
  15. e-Support Services
  16. eMedical Benefit Verification
  17. iAssist
  18. Patient Access
  19. Patient Education & Adherence
  20. Patient Financial Assistance
  21. Patient Support Programs
  22. Price Transparency
  23. Retail
  24. Specialty Pharmacy Network
  25. Specialty Therapies
  26. Specialty-Lite
Industry Insights

Drug Channels – The AI Advantage: When and Where to Apply It in Your Patient Support Program

Artificial intelligence (AI) is transforming how life sciences organizations approach drug development, diagnostics, personalized care and more. Now, many are exploring how AI can enhance patient support programs (PSPs) by improving efficiency, patient and healthcare provider experiences and improved outcomes. In this Drug Channels Institute article, Chief Product Officer William...

Read more
Press Releases

AssistRx Completes Asset Acquisition from AllazoHealth, Strengthening its Advanced Tech + Talent Patient Support Services

Tech-first therapy initiation and patient solutions provider enhances and augments services with artificial intelligence-powered patient engagement. Orlando, Fla. – April 2, 2025 – AssistRx, the advanced therapy initiation and patient solutions provider, today announced it has completed an asset acquisition from AllazoHealth, a healthcare technology company driving therapy initiation, adherence...

Read more
Industry Insights

Drug Channels – Direct-to-Consumer Models: Why They’re Expanding and Where They Deliver the Most Impact

Since early 2024, life sciences organizations have increasingly adopted direct-to-consumer (DTC) models to simplify patient access, reduce costs and address market challenges. While DTC models offer advantages in convenience and market positioning, it also introduces complexities in implementation, compliance and data security.In this Drug Channels Institute article, Vice President of...

Read more
Load more
loader

Subscribe to Our Perspectives Newsletter

Be the first to access resources and insights on how to drive timely therapy access, improved ongoing patient support, and enhanced provider and patient experiences.

Subscribe to mailing list